Exxon Mobil Corp
Change company Symbol lookup
Select an option...
XOM Exxon Mobil Corp
BELFB Bel Fuse Inc
SRCL Stericycle Inc
TWTR Twitter Inc
CSTL Castle Biosciences Inc
LH Laboratory Corporation of America Holdings
ET Energy Transfer LP
BG Bunge Ltd
MSB Mesabi Trust
TRC Tejon Ranch Co
Go

Energy : Oil, Gas & Consumable Fuels | Large Cap Value
Company profile

Exxon Mobil Corporation is engaged in energy business. The Company’s principal business involves exploration for, and production of, crude oil and natural gas, and the manufacture, trade, transport and sale of crude oil, natural gas, petroleum products, petrochemicals and a range of specialty products. The Company's segments include Upstream, Downstream and Chemical. The Upstream segment is organized and operates to explore for and produce crude oil and natural gas. The Downstream segment manufactures, trades and sells petroleum products. The refining and supply operations encompass a global network of manufacturing plants, transportation systems, and distribution centers that provide a range of fuels, lubricants and other products and feedstocks to its customers around the world. The Chemical segment is organized and operates to manufacture and sell petrochemicals. The Chemical business supplies olefins, polyolefins, aromatics, and a variety of other petrochemicals.

Closing Price
$88.86
Day's Change
3.12 (3.64%)
Bid
--
Ask
--
B/A Size
--
Day's High
89.30
Day's Low
85.92
Volume
(Average)
Volume:
19,543,315

10-day average volume:
21,044,400
19,543,315

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Professional Holding Corp. (Nasdaq - PFHD), Global Blood Therapeutics, Inc. (Nasdaq - GBT), CyberOptics Corporation (Nasdaq - CYBE), EVO Payments, Inc. (Nasdaq - EVOP)

12:32 pm ET August 11, 2022 (Globe Newswire) Print

Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Professional Holding Corp. (Nasdaq - PFHD)

Under the terms of the agreement, Professional will be acquired by Seacoast Banking Corporation of Florida ("Seacoast") (Nasdaq -SBCF). Professional shareholders are to receive 0.8909 shares of Seacoast common stock for each share of Professional common stock. The exchange ratio for the transaction is fixed, which means that the transaction value will fluctuate as a result of changes in Seacoast's stock price. Based on Seacoast's closing price of $36.75 per share on August 5, 2022, the implied consideration is $32.74 per share and the transaction is valued at approximately $488.6 million. The investigation concerns whether the Professional Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Seacoast paying too little for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/professional-holding-corp-nasdaq-pfhd/.

Global Blood Therapeutics, Inc. (Nasdaq - GBT)

Under the terms of the agreement, GBT will be acquired by Pfizer Inc. (NYSE - PFE). Pfizer will acquire GBT for $68.50 per share in cash for each outstanding share of common stock held for a total enterprise value of approximately $5.4 billion, including debt and net of cash acquired. The investigation concerns whether the GBT Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Pfizer is paying too little for the Company. For example, the deal consideration is below the 52-week high of $73.02 for the Company's shares.

Additional information can be found at https://www.brodskysmith.com/cases/global-blood-therapeutics-inc-nasdaq-gbt/.

CyberOptics Corporation (Nasdaq - CYBE)

Under the terms of the agreement, CyberOptics will be acquired by Nordson Corporation ("Nordson") (Nasdaq - NDSN). Nordson will acquire CyberOptics for $54.00 per share in cash for each outstanding share of common stock held. The investigation concerns whether the CyberOptics Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Nordson is paying too little for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/cyberoptics-corporation-nasdaq-cybe/.

EVO Payments, Inc. (Nasdaq - EVOP)

Under the terms of the agreement, EVO Payments will be acquired by Global Payments Inc. (NYSE - GPN). Global Payments will acquire the outstanding equity of EVO Payments for $34.00 per share in cash ($4.0 billion of enterprise value for the Company). The investigation concerns whether the EVO Payments Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Global Payments Inc. is paying too little for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/evo-payments-inc-nasdaq-evop/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png

https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png

comtex tracking

COMTEX_412085828/2010/2022-08-11T12:32:29

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.